<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Physiology</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Physiology</journal-title><trans-title-group xml:lang="ru"><trans-title>Российский физиологический журнал им. И.М. Сеченова</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0869-8139</issn><issn publication-format="electronic">2658-655X</issn><publisher><publisher-name xml:lang="en">The Russian Academy of Sciences</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">651564</article-id><article-id pub-id-type="doi">10.31857/S0869813923050072</article-id><article-id pub-id-type="edn">XRCARE</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>EXPERIMENTAL ARTICLES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ЭКСПЕРИМЕНТАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Tim-3, CD9 Molecule Expressions on Natural Killer (NK) and T-Lymphocytes with NK Functions (NKT) of the Peripheral Blood at Different Trimesters of Physiological Pregnancy</article-title><trans-title-group xml:lang="ru"><trans-title>Экспрессия молекул Tim-3 и CD9 на натуральных киллерах (NK) и Т-лимфоцитах с функциями NK (NKT) периферической крови в разные сроки физиологической беременности</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Orlova</surname><given-names>E. G.</given-names></name><name xml:lang="ru"><surname>Орлова</surname><given-names>Е. Г.</given-names></name></name-alternatives><email>orlova_katy@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Loginova</surname><given-names>О. А.</given-names></name><name xml:lang="ru"><surname>Логинова</surname><given-names>О. А.</given-names></name></name-alternatives><email>orlova_katy@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Gorbunova</surname><given-names>О. L.</given-names></name><name xml:lang="ru"><surname>Горбунова</surname><given-names>О. Л.</given-names></name></name-alternatives><email>orlova_katy@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Karimova</surname><given-names>N. V.</given-names></name><name xml:lang="ru"><surname>Каримова</surname><given-names>Н. В.</given-names></name></name-alternatives><email>orlova_katy@mail.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Shirshev</surname><given-names>S. V.</given-names></name><name xml:lang="ru"><surname>Ширшев</surname><given-names>С. В.</given-names></name></name-alternatives><email>orlova_katy@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Institute of Ecology and Genetics of Microorganisms RAS – Branch 
of Perm Federal Research Center UB RAS</institution></aff><aff><institution xml:lang="ru">Институт экологии и генетики микроорганизмов УрО РАН</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">LLC Centralized Clinical and Diagnostic Laboratory</institution></aff><aff><institution xml:lang="ru">ООО Централизованная клинико-диагностическая лаборатория</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2023-05-01" publication-format="electronic"><day>01</day><month>05</month><year>2023</year></pub-date><volume>109</volume><issue>5</issue><fpage>572</fpage><lpage>587</lpage><history><date date-type="received" iso-8601-date="2025-02-01"><day>01</day><month>02</month><year>2025</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2023, Е.Г. Орлова, О.А. Логинова, О.Л. Горбунова, Н.В. Каримова, С.В. Ширшев</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2023, Е.Г. Орлова, О.А. Логинова, О.Л. Горбунова, Н.В. Каримова, С.В. Ширшев</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="en">Е.Г. Орлова, О.А. Логинова, О.Л. Горбунова, Н.В. Каримова, С.В. Ширшев</copyright-holder><copyright-holder xml:lang="ru">Е.Г. Орлова, О.А. Логинова, О.Л. Горбунова, Н.В. Каримова, С.В. Ширшев</copyright-holder></permissions><self-uri xlink:href="https://journals.eco-vector.com/0869-8139/article/view/651564">https://journals.eco-vector.com/0869-8139/article/view/651564</self-uri><abstract xml:lang="en"><p id="idm45181322861488">Natural killer cells (NK) and T-lymphocytes with NK functions (NKT) are the leading effectors of the mother’s immune tolerance to a semi-allogeneic fetus and have a fetal trophic effect during physiological pregnancy. Tim-3 (T-cell Ig and mucin domain-containing protein 3) and CD9 molecules play a critical role in the immunoregulatory and fetal trophic functions of NK and NKT, but their expression in peripheral blood cells has not been studied. The aim of this work was to study the expression of Tim-3 and CD9 in peripheral blood NK and NKT during physiological pregnancy. The object of the study was the peripheral blood of healthy women in I and III trimesters of a physiological pregnancy. The control group consisted of healthy non-pregnant women in the first phase of the menstrual cycle. Expression of Tim-3, CD9 molecules was analyzed by flow cytometry on regulatory NK (CD16<sup>–</sup>CD56<sup>bright</sup>) and NKT (CD16<sup>–</sup>CD56<sup>+</sup>), cytotoxic NK (CD16<sup>+</sup>CD56<sup>dim/–</sup>) and NKT (CD16<sup>+</sup>CD56<sup>+</sup>). It was found that in the first trimester of pregnancy, the total number and subpopulation composition of NK and NKT cells did not change. Tim-3 expression increased in all NK and NKT subpopulations, except for cytotoxic CD16<sup>+</sup>CD56<sup>dim</sup>NK. CD9 expression increased in all NK subpopulations, but in NKT did not differ from non-pregnant. At the same time, a direct correlation between CD9 and Tim-3 expressions was revealed in regulatory NK and NKT in the first trimester of pregnancy. In the third trimester, the regulatory CD16<sup>–</sup>CD56<sup>bright</sup>NK number increased, while cytotoxic CD16<sup>+</sup>CD56<sup>dim</sup>NK and regulatory CD16<sup>–</sup>CD56<sup>+</sup>NKT decreased compared to non-pregnant women. The number of CD16<sup>+</sup>CD56<sup>–</sup>NK did not change in I and III trimesters of a physiological pregnancy. Tim-3 expression was upregulated in all NK and cytotoxic NKT subpopulations, while CD9 was upregulated only in regulatory NKs. Thus, Tim-3 and CD9 molecule expressions of s on different NK and NKT subpopulations changed during I and III trimesters of a physiological pregnancy, which plays an important role in the regulation of their phenotype and functions.</p></abstract><trans-abstract xml:lang="ru"><p id="idm45181322859344">При физиологически протекающей беременности натуральные киллеры (NK) и Т-лимфоциты с функциями NK (NKT) являются ведущими эффекторами иммунной толерантности организма матери к полуаллогенному плоду, а также выполняют фетотрофическую функцию. Молекулы Tim-3 (T-cell Ig and mucin domain-containing protein 3) и CD9 играют критическую роль в реализации иммунорегуляторной и фетотрофической функций NK и NKT, однако их экспрессия на клетках периферической крови не изучена. Цель работы – исследовать экспрессию Tim-3, CD9 на субпопуляциях NK и NKT периферической крови в разные сроки физиологически протекающей беременности. Объектом исследования являлась периферическая кровь условно-здоровых женщин в I и III триместрах физиологически протекающей беременности. Группу сравнения составили условно-здоровые небеременные женщины в I фазе менструального цикла. Экспрессию молекул Tim-3, CD9 анализировали методом проточной цитофлюориметрии на регуляторных NK (CD16<sup>–</sup>CD56<sup>bright</sup>) и NKT (CD16<sup>–</sup>CD56<sup>+</sup>), цитотоксических NK (CD16<sup>+</sup>CD56<sup>dim/–</sup>) и NKT (CD16<sup>+</sup>CD56<sup>+</sup>). Установлено, что в I триместре беременности количество и соотношение регуляторных и цитотоксических NK и NKT не менялось. Экспрессия Tim-3 увеличивалась на всех субпопуляциях NK и NKT за исключением цитотоксических CD16<sup>+</sup>CD56<sup>dim</sup>NK. Экспрессия CD9 возрастала на всех субпопуляциях NK, а на NKT не отличалась от небеременных. При этом на регуляторных NK и NKT в I триместре беременности выявлена прямая корреляция экспрессии CD9 и Tim-3. В III триместре количество регуляторных CD16<sup>–</sup>CD56<sup>bright</sup>NK увеличивалось, а цитотоксических CD16<sup>+</sup>CD56<sup>dim</sup>NK и регуляторных CD16<sup>–</sup>CD56<sup>+</sup>NKТ снижалось по сравнению с небеременными. Количество CD16<sup>+</sup>CD56<sup>–</sup>NK не менялось по триместрам беременности. Экспрессия Tim-3 усиливалась на всех субпопуляциях NK и цитотоксических NKТ, а CD9 повышалась только на регуляторных NK. Таким образом, экспрессия молекул Tim-3 и CD9 на разных субпопуляциях NK и NKT менялась по триместрам, что играет важную роль в регуляции их фенотипа и функций при беременности.</p></trans-abstract><kwd-group xml:lang="en"><kwd>natural killers</kwd><kwd>T-lymphocytes with natural killer functions</kwd><kwd>Tim-3</kwd><kwd>CD9</kwd><kwd>pregnancy</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>натуральные киллеры</kwd><kwd>T-лимфоциты с функциями натуральных киллеров</kwd><kwd>Tim-3</kwd><kwd>СD9</kwd><kwd>беременность</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Saito S, Nakashima A, Myojo-Higuma S, Shiozaki A (2008) The balance between cytotoxic NK cells and regulatory NK cells in human pregnancy. J Reprod Immunol 77(1): 14–22. https://doi.org/10.1016/j.jri.2007.04.007</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Shojaei Z, Jafarpour R, Mehdizadeh S, Bayatipoor H, Pashangzadeh S, Motallebnezhad M (2022) Functional prominence of natural killer cells and natural killer T cells in pregnancy and infertility: A comprehensive review and update. Pathol Res Pract 238: 154062. https://doi.org/10.1016/j.prp.2022.154062</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Di Santo JP (2008) Functionally distinct NK-cell subsets: developmental origins and biological implications. Eur J Immunol 38(11): 2948–2951. https://doi.org/10.1002/eji.200838830</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Veenstra van Nieuwenhoven AL, Bouman A, Moes H, Heineman MJ, de Leij LF, Santema J, Faas MM (2002) Cytokine production in natural killer cells and lymphocytes in pregnant women compared with women in the follicular phase of the ovarian cycle. Fertil Steril 77(5): 1032–1037. https://doi.org/10.1016/s0015-0282(02)02976-x</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Wijaya RS, Read SA, Schibeci S, Han S, Azardaryany MK, van der Poorten D, Lin R, Yuen L, Lam V, Douglas MW, George J, Ahlenstiel G. (2021). Expansion of dysfunctional CD56–CD16+ NK cells in chronic hepatitis B patients. Liver Int: Offic J Int Associat Study Liver, 41(5): 969–981. https://doi.org/10.1111/liv.14784</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Orrantia A, Terrén I, Izquierdo-Lafuente A, Alonso-Cabrera JA, Sandá V, Vitallé J, Moreno S, Tasias M, Uranga A, González C, Mateos JJ, García-Ruiz JC, Zenarruzabeitia O, Borrego F (2020) A NKp80-Based Identification Strategy Reveals that CD56neg NK Cells Are Not Completely Dysfunctional in Health and Disease. Science 23(7): 101298. https://doi.org/10.1016/j.isci.2020.101298</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Cocker ATH, Liu F, Djaoud Z, Guethlein LA, Parham P (2022) CD56-negative NK cells: Frequency in peripheral blood, expansion during HIV-1 infection, functional capacity and KIR expression. Front Immunol 13: 992723. https://doi.org/10.3389/fimmu.2022.992723</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Whettlock EM, Woon EV, Cuff AO, Browne B, Johnson MR, Male V (2022) Dynamic Changes in Uterine NK Cell Subset Frequency and Function Over the Menstrual Cycle and Pregnancy. Front Immunol 13: 880438. https://doi.org/10.3389/fimmu.2022.880438</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Koopman LA, Kopcow HD, Rybalov B, Boyson JE, Orange JS, Schatz F, Masch R, Lockwood CJ, Schachter AD, Park PJ, Strominger JL (2003) Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J Exp Med 198(8): 1201–1212. https://doi.org/10.1084/jem.20030305</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Михайлова ВА, Белякова КЛ, Сельков СА, Соколов ДИ (2017) Особенности дифференцировки NK-клеток: CD56dim и CD56bright NK-клетки во время и вне беременности. Мед иммунол 19(1): 19–26. [Mikhailova VA, Belyakova KL, Selkov SA, Sokolov DI (2017) Features of NK cell differentiation: CD56dim and CD56bright NK cells during and outside pregnancy. Med Immunol 19(1): 19–26. (In Russ)]. https://doi.org/10.15789/1563-0625-2017-1-19-26</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Sotnikova N, Voronin D, Antsiferova Y, Bukina E (2014) Interaction of decidual CD56+ NK with trophoblast cells during normal pregnancy and recurrent spontaneous abortion at early term of gestation. Scand J Immunol 80(3): 198–208. https://doi.org/10.1111/sji.12196</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Du X, Zhu H, Jiao D, Nian Z, Zhang J, Zhou Y, Zheng X, Tong X, Wei H, Fu B (2022) Human-induced CD49a+NK Cells promote fetal growth. Front Immunol 13: 821542. https://doi.org/10.3389/fimmu.2022.821542</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Khademi M, Illés Z, Gielen AW, Marta M, Takazawa N, Baecher-Allan C, Brundin L, Hannerz J, Martin C, Harris RA, Hafler DA, Kuchroo VK, Olsson T, Piehl F, Wallström ET (2004) Cell Ig-and mucin-domain-containing molecule-3 (TIM-3) and TIM-1 molecules are differentially expressed on human Th1 and Th2 cells and in cerebrospinal fluid-derived mononuclear cells in multiple sclerosis. J Immunol 172(11): 7169–7176. https://doi.org/10.4049/jimmunol.172.11.7169</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Sun J, Yang M, Ban Y, Gao W, Song B, Wang Y, Zhang Y, Shao Q, Kong B, Qu X (2016) Tim-3 Is upregulated in NK cells during early pregnancy and inhibits NK cytotoxicity toward trophoblast in galectin-9 dependent pathway. PloS One 11(1): e0147186. https://doi.org/10.1371/journal.pone.0147186</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Zhu C, Anderson AC, Schubart A, Xiong H, Imitola J, Khoury SJ, Zheng XX, Strom TB, Kuchroo VK (2005)The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol 6(12): 1245–1252. https://doi.org/10.1038/ni1271</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Hou H, Liu W, Wu S, Lu Y, Peng J, Zhu Y, Lu Y, Wang F, Sun Z (2014) Tim-3 negatively mediates natural killer cell function in LPS-induced endotoxic shock. PLoS One 9(10): e110585. https://doi.org/10.1371/journal.pone.0110585</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Meggyes M, Lajko A, Palkovics T, Totsimon A, Illes Z, Szereday L, Miko E (2015). Feto-maternal immune regulation by TIM-3/galectin-9 pathway and PD-1 molecule in mice at day 14.5 of pregnancy. Placenta 36(10): 1153–1160. https://doi.org/10.1016/j.placenta.2015.07.124</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Cerdeira AS, Rajakumar A, Royle CM, Lo A, Husain Z, Thadhani RI, Sukhatme VP, Karumanchi SA, Kopcow HD (2013). Conversion of peripheral blood NK cells to a decidual NK-like phenotype by a cocktail of defined factors. J Immunol (Baltimore, Md: 1950), 190(8): 3939–3948. https://doi.org/10.4049/jimmunol.1202582</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Reyes R, Cardeñes B, Machado-Pineda Y, Cabañas C (2018) Tetraspanin CD9: A key regulator of cell adhesion in the immune system. Front Immunol 9: 863. https://doi.org/10.3389/fimmu.2018.00863</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Lee CL, Vijayan M, Wang X, Lam KKW, Koistinen H, Seppala M, Li RHW, Ng EHY, Yeung WSB, Chiu PCN (2019) Glycodelin-A stimulates the conversion of human peripheral blood CD16-CD56bright NK cell to a decidual NK cell-like phenotype. Hum Reprod 34(4): 689–701. https://doi.org/10.1093/humrep/dey378</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Орлова ЕГ, Логинова ОА, Горбунова ОЛ, Каримова НВ, Ширшев СВ (2022) Особенности экспрессии молекул Tim-3, CD9, CD49a лимфоцитами периферической крови при физиологической беременности. [Электронный ресурс] Вестн уральской мед акад науки 19(5): 461–473. [Orlova EG, Loginova ОА, Gorbunova ОL, Karimova NV, Shirshev SV (2022) Features of TIM-3, CD9, CD49a molecule expressions by peripheral blood lymphocytes during physiological pregnancy. [Online] Vestn Ural Med Akad Nauki 19(5): 461–473. (In Russ)]. https://doi.org/10.22138/2500-0918-2022-19-5-461-473</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Moore T, Dveksler GS (2014) Pregnancy-specific glycoproteins: complex gene families regulating maternal-fetal interactions. Int J Dev Biol 58(2–4): 273–280. https://doi.org/10.1387/ijdb.130329gd</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Kronenberg M, Gapin L (2002) The unconventional lifestyle of NKT cells. Nat Rev Immunol 2: 557–568. https://doi.org/dx.doi.org/10.1038/nri854</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Vitelli-Avelar DM, Sathler-Avelar R, Dias JC, Pascoal VP, Teixeira-Carvalho A, Lage PS, Elói-Santos SM, Corrêa-Oliveira R, Martins-Filho OA (2005) Chagasic patients with indeterminate clinical form of the disease have high frequencies of circulating CD3+CD16–CD56+ natural killer T cells and CD4+CD25 high regulatory T lymphocytes. Scand J Immunol 62(3): 297–308. https://doi.org/10.1111/j.1365-3083.2005.01668.x</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Yuan J, Li J, Huang SY, Sun X (2015) Characterization of the subsets of human NKT-like cells and the expression of Th1/Th2 cytokines in patients with unexplained recurrent spontaneous abortion. J Reprod Immunol 110: 81–88. https://doi.org/10.1016/j.jri.2015.05.001</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Godfrey DI, MacDonald HR, Kronenberg M, Smyth MJ, Van Kaer L (2004) NKT cells: what’s in a name? Nature Rev Immunol 4(3): 231–237. https://doi.org/10.1038/nri1309</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Borzychowski AM, Croy BA, Chan WL, Redman CWG, Sargent IL (2005) Changes in systemic type 1 and type 2 immunity in normal pregnancy and preeclampsia may be mediated by natural killer cells. Eur J Immunol 35: 3054–3063. https://doi.org/10.1002/eji.200425929</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Boyson JE, Rybalov B, Koopman LA, Exley M, Balk SP, Racke FK, Schatz F, Masch R, Wilson SB, Strominger JL (2002) CD1d and invariant NKT cells at the human maternal-fetal interface. Proc Natl Acad Sci U S A 9(21): 13741–13746. https://doi.org/10.1073/pnas.162491699</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Shi Y, Ling B, Zhou Y, Gao T, Feng D, Xiao M, Feng L (2007) Interferon-gamma expression in natural killer cells and natural killer T cells is suppressed in early pregnancy. Cell Mol Immunol 4(5): 389–394.</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Southcombe J, Redman C, Sargent I (2010) Peripheral blood invariant natural killer T cells throughout pregnancy and in preeclamptic women. J Reprod Immunol 87(1–2): 52–59. https://doi.org/10.1016/j.jri.2010.07.003</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Van den Heuvel MJ, Peralta CG, Hatta K, Han VK, Clark DA (2007) Decline in number of elevated blood CD3+ CD56+ NKT cells in response to intravenous immunoglobulin treatment correlates with successful pregnancy. Am J Reprod Immunol 58(5): 447–459. https://doi.org/10.1111/j.1600-0897.2007.00529.x</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Hosseini S, Shokri F, Pour SA, Khoshnoodi J, Jeddi-Tehrani M, Zarnani AH (2019) Diminished frequency of menstrual and peripheral blood NKT-like cells in patients with unexplained recurrent spontaneous abortion and infertile women. Reprod Sci 26(1): 97–108. https://doi.org/10.1177/1933719118766261</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Ito K, Karasawa M, Kawano T, Akasaka T, Koseki H, Akutsu Y, Kondo E, Sekiya S, Sekikawa K, Harada M, Yamashita M, Nakayama T, Taniguchi M (2000) Involvement of decidual Vα14 NKT cells in abortion. Proc Natl Acad Sci U S A 97(2): 740–744. https://doi.org/10.1073/pnas.97.2.740</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Lajko A, Meggyes M, Polgar B, Szereday L (2018) The immunological effect of Galectin-9/TIM-3 pathway after low dose Mifepristone treatment in mice at 14.5 day of pregnancy. PLoS One 13(3): e0194870. https://doi.org/10.1371/journal.pone.0194870</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Trittel S, Vashist N, Ebensen T, Chambers BJ, Guzmán CA, Riese P (2019) Invariant NKT cell-mediated modulation of ILC1s as a tool for mucosal immune intervention. Front Immunol 10: 1849. https://doi.org/10.3389/fimmu.2019.01849</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Ширшев СВ (2009) Иммунология материнско-фетальных взаимодействий. Екатеринбург. УрО РАН. [Shirshev SV (2009) Immunology of maternal-fetal interactions. Ekaterinburg. (In Russ)].</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Szekeres-Bartho J (2009) Progesterone-mediated immunomodulation in pregnancy: its relevance to leukocyte immunotherapy of recurrent miscarriage. Immunotherapy (5): 873–882. PMID: https://doi.org/10.2217/imt.09.5420636029</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Gutierrez C (1979) Purification of human T and B cells by a discontinuous density gradient of percoll. J Immunol Methods 29(1): 57–63. https://doi.org/10.1016/0022-1759(79)90125-x</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>De Andrés C, Fernández-Paredes L, Tejera-Alhambra M, Alonso B, Ramos-Medina R, Sánchez-Ramón S (2017) Activation of Blood CD3+CD56+CD8+ T cells during pregnancy and multiple sclerosis. Front Immunol 8: 196. https://doi.org/10.3389/fimmu.2017.00196</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Zhou J, Zhao X, Wang Z, Wang J, Sun H, Hu Y (2013) High circulating CD3+CD56+CD16+ natural killer-like T cell levels predict a better IVF treatment outcome. J Reprod Immunol 97(2): 197–203. https://doi.org/10.1016/j.jri.2012.12.006</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>Meggyes M, Miko E, Polgar B, Bogar B, Farkas B, Illes Z, Szereday L (2014) Peripheral blood TIM-3 positive NK and CD8+ T cells throughout pregnancy: TIM-3/galectin-9 interaction and its possible role during pregnancy. PloS One 9(3): e92371. https://doi.org/10.1371/journal.pone.0092371</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>Williams PJ, Searle RF, Robson SC. Innes BA, Bulmer JN (2009) Decidual leucocyte populations in early to late gestation normal human pregnancy. J Reprod Immunol 82(1): 24–31. https://doi.org/10.1016/j.jri.2009.08.001</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>Gemelli M, Noonan DM, Carlini V, Pelosi G, Barberis M, Ricotta R, Albini A (2022) Overcoming resistance to checkpoint Inhibitors: natural killer cells in non-small cell lung cancer. Front Oncol 12: 886440. https://doi.org/10.3389/fonc.2022.886440</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>Meggyes M, Nagy DU, Saad Al Deen I, Parkanyi B, Szereday L (2023) CD8+ and CD8– NKT cells exhibit phenotypic changes during pregnancy. Immunol Invest 52(1): 35–57. https://doi.org/10.1080/08820139.2022.2119863</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>Mikhailova VA, Kudryavtsev IV, Serebryakova MK, Milyutina YP, Demidova ES, Panina AN, Bazhenov DO, Belikova ME, Selkov SA, Sokolov DI (2020) Trophoblast cell influence on peripheral blood natural killer cell proliferation and phenotype in non-pregnant women and women in early pregnancy. Immunobiology 225(3): 151910. https://doi.org/10.1016/j.imbio.2020.151910</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>Arruvito L, Giulianelli S, Flores AC, Paladino N, Barboza M, Lanari C, Fainboim L (2008) NK cells expressing a progesterone receptor are susceptible to progesterone-induced apoptosis. J Immunol 180(8): 5746–5753. https://doi.org/10.4049/jimmunol.180.8.5746</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>Shirshev SV, Nekrasova IV, Gorbunova OL, Orlova EG (2017) Hormonal regulation of NK cell cytotoxic activity. Dokl Biol Sci 472(1): 28–30. https://doi.org/10.1134/S0012496617010021</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>Shirshev SV, Nekrasova IV, Gorbunova OL, Orlova EG, Maslennikova IL (2017) MicroRNA in hormonal mechanisms of regulation of NK cell function. Dokl Biochem Biophys 474(1): 168–172. https://doi.org/10.1134/S160767291703005X</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation>Mikhailova V, Grebenkina P, Khokhlova E, Davydova A, Salloum Z, Tyshchuk E, Zagainova V, Markova K, Kogan I, Selkov S, Sokolov D (2022) Pro- and Anti-Inflammatory Cytokines in the Context of NK Cell-Trophoblast Interactions. Int J Mol Sci 23(4): 2387. https://doi.org/10.3390/ijms23042387</mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation>Van den Heuvel MJ, Chantakru S, Xuemei X, Evans SS, Tekpetey F, Mote PA, Clarke CL, Croy BA (2005) Trafficking of circulating pro-NK cells to the decidualizing uterus: regulatory mechanisms in the mouse and human. Immunol Invest 34(3): 273–293. https://doi.org/10.1081/imm-200064488</mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation>Shinomiya N, Tsuru S, Tsugita M, Katsura Y, Takemura T, Roku-tanda M, Nomoto K (1991) Thymic depletion in pregnancy: kinetics ofthymocytes and immunologic capacities of the hosts. J Clin Lab Immunol 34: 11–22.</mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation>Montaldo E, Vacca P, Chiossone L, Croxatto D, Loiacono F, Martini S, Ferrero S, Walzer T, Moretta L, Mingari MC (2016) Unique eomes(+) NK cell subsets are present in uterus and decidua during early pregnancy. Front Immunol 6: 646. https://doi.org/10.3389/fimmu.2015.00646</mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation>Albini A, Gallazzi M, Palano MT, Carlini V, Ricotta R, Bruno A, Stetler-Stevenson WG, Noonan DM (2021) TIMP1 and TIMP2 downregulate TGFβ induced decidual-like phenotype in natural killer cells. Cancers (Basel) 13(19): 4955. https://doi.org/10.3390/cancers13194955</mixed-citation></ref></ref-list></back></article>
